<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01784250</url>
  </required_header>
  <id_info>
    <org_study_id>CLON000</org_study_id>
    <nct_id>NCT01784250</nct_id>
  </id_info>
  <brief_title>Efficacy of Clonidine and Propranolol in Dentistry (AAA)</brief_title>
  <official_title>Efficacy of Clonidine and Propranolol Versus Placebo for the Control of Anxiety During Surgical Procedures in Dentistry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>CES University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>CES University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to determine the efficacy of clonidine and propranolol for transient
      anxiety management and intra and postoperative pain in patients undergoing ambulatory surgery
      of third molar.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      There will be a randomized, triple-blind, placebo-controlled clinical trial with parallel
      group design to determine the efficacy of the pre medication propranolol and clonidine versus
      placebo for reducing anxiety during third molar removal surgery. Patients will be assigned to
      3 groups of 20 patients each. One group will receive 150 mcg of clonidine, the second group
      will receive propranolol 40mg, and the control group will receive placebo. The modified
      dental anxiety scale will be applied before and after surgery in order to evaluate the change
      in anxiety level, which will be assessed as the primary outcome. The secondary outcomes
      include the measurement of changes in blood pressure, heart rate and respiratory rate
      evaluated before, during and after surgery. Additionally, pain will be assessed through
      numerical pain scale at 3, 6 and 24 hours after surgery. Also, possible side effects will be
      identified (vomiting, nausea, dry mouth, dizziness and drowsiness). Statistical analysis:
      qualitative variables will be described by absolute and relative frequencies, and
      quantitative variables will be described by the mean along with standard deviation or the
      median with interquartile range depending on the distribution of the data. One-way ANOVA or
      Kruskal Wallis will be used (depending on the fulfillment of assumptions) in order to compare
      the quantitative variables amongst the groups. The chi squared test will be used to compare
      the qualitative variables. The confidence intervals will be estimated at 95% for all effect
      magnitude measurements calculated.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>August 2012</start_date>
  <completion_date type="Anticipated">April 2013</completion_date>
  <primary_completion_date type="Anticipated">April 2013</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline in modified dental anxiety scale(MDAS)and vital signs (blood pressure, heart rate, respiratory rate, oxygen saturation) until four hours post treatment</measure>
    <time_frame>(plus or minus 4 hours) after surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in Verbal Numerical Rating Scale (VNRS) at three, six, and twenty-four hours post treatment</measure>
    <time_frame>24 hours</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Frequency of side effects in patients treated with clonidine and propranolol compared with placebo after third molar surgery</measure>
    <time_frame>24 hours</time_frame>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Anxiety</condition>
  <arm_group>
    <arm_group_label>Propanolol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Propranolol 40mg tablets, one tablet administered 1 hour before surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo tablets, one tablet administered 1 hour before surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Clonidine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>clonidine 150mcg tablets, one tablet administered 1 hour before surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Clonidine</intervention_name>
    <description>Clonidine 150 mcg tablet single dose, to receive by mouth one hour before surgery</description>
    <arm_group_label>Clonidine</arm_group_label>
    <other_name>Catapresan</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propranolol</intervention_name>
    <description>Propranolol 40 mg tablet single dose, to receive by mouth one hour before surgery</description>
    <arm_group_label>Propanolol</arm_group_label>
    <other_name>Artensol</other_name>
    <other_name>Inderal</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Sugar pill manufactured to mimic a drug</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Normotensive patients and pre-hypertension who are undergoing elective surgery for
             removal of third molars.

          -  Age range 14 to 40 years

          -  Patients with dental anxiety above 13 points on the scale (MDAS).

          -  People who voluntarily agree to participate in the study and sign the informed consent
             form

        Exclusion Criteria:

          -  Patients receiving any medication for any chronic pathology.

          -  Patients of African American race, being more likely to have abnormal blood pressure.

          -  Patients with a history of cardiovascular disease.

          -  Patients with chronic systemic disease such as diabetes, hyper or hypothyroidism,
             Addison's syndrome, renal failure, hypertension or liver disease.

          -  Pregnant or breastfeeding.

          -  Patients diagnosed with anxiety disorder or depressive disorder
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>14 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Patricia Bermudez, Dentistry</last_name>
    <role>Principal Investigator</role>
    <affiliation>CES University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Libia M Rodriguez, Magister</last_name>
    <role>Study Director</role>
    <affiliation>CES University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ana K Tamara, Physician</last_name>
    <role>Principal Investigator</role>
    <affiliation>CES University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cooperative University</name>
      <address>
        <city>Envigado</city>
        <state>Antioquia</state>
        <country>Colombia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patricia Bermudez, Dentistry</last_name>
      <email>patvanss@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Ana K Tamara, Physician</last_name>
      <email>anakarinatamarae@hotmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Colombia</country>
  </location_countries>
  <reference>
    <citation>Ng SK, Leung WK. A community study on the relationship of dental anxiety with oral health status and oral health-related quality of life. Community Dent Oral Epidemiol. 2008 Aug;36(4):347-56.</citation>
    <PMID>19145721</PMID>
  </reference>
  <reference>
    <citation>Kvale G, Berggren U, Milgrom P. Dental fear in adults: a meta-analysis of behavioral interventions. Community Dent Oral Epidemiol. 2004 Aug;32(4):250-64.</citation>
    <PMID>15239776</PMID>
  </reference>
  <reference>
    <citation>Lago-Méndez L, Diniz-Freitas M, Senra-Rivera C, Seoane-Pesqueira G, Gándara-Rey JM, García-García A. Postoperative recovery after removal of a lower third molar: role of trait and dental anxiety. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009 Dec;108(6):855-60. doi: 10.1016/j.tripleo.2009.07.021.</citation>
    <PMID>19913724</PMID>
  </reference>
  <reference>
    <citation>Humphris GM, Dyer TA, Robinson PG. The modified dental anxiety scale: UK general public population norms in 2008 with further psychometrics and effects of age. BMC Oral Health. 2009 Aug 26;9:20. doi: 10.1186/1472-6831-9-20.</citation>
    <PMID>19709436</PMID>
  </reference>
  <reference>
    <citation>Hall DL, Tatakis DN, Walters JD, Rezvan E. Oral clonidine pre-treatment and diazepam/meperidine sedation. J Dent Res. 2006 Sep;85(9):854-8.</citation>
    <PMID>16931871</PMID>
  </reference>
  <reference>
    <citation>Liu HH, Milgrom P, Fiset L. Effect of a beta-adrenergic blocking agent on dental anxiety. J Dent Res. 1991 Sep;70(9):1306-8.</citation>
    <PMID>1918581</PMID>
  </reference>
  <reference>
    <citation>Herr KA, Spratt K, Mobily PR, Richardson G. Pain intensity assessment in older adults: use of experimental pain to compare psychometric properties and usability of selected pain scales with younger adults. Clin J Pain. 2004 Jul-Aug;20(4):207-19.</citation>
    <PMID>15218405</PMID>
  </reference>
  <verification_date>February 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 23, 2013</study_first_submitted>
  <study_first_submitted_qc>February 2, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 5, 2013</study_first_posted>
  <last_update_submitted>February 2, 2013</last_update_submitted>
  <last_update_submitted_qc>February 2, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 5, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>CES University</investigator_affiliation>
    <investigator_full_name>Patricia Bermúdez Reyes</investigator_full_name>
    <investigator_title>Researcher</investigator_title>
  </responsible_party>
  <keyword>Clonidine</keyword>
  <keyword>Propranolol</keyword>
  <keyword>Third molar</keyword>
  <keyword>Anxiety</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anxiety Disorders</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propranolol</mesh_term>
    <mesh_term>Clonidine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

